396 related articles for article (PubMed ID: 33974093)
21. Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications.
Rudokas M; Najlah M; Alhnan MA; Elhissi A
Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):60-72. PubMed ID: 26938856
[TBL] [Abstract][Full Text] [Related]
22. Liposomes as a Promising Ultrasound-Triggered Drug Delivery System in Cancer Treatment.
Salkho NM; Turki RZ; Guessoum O; Martins AM; Vitor RF; Husseini GA
Curr Mol Med; 2017; 17(10):668-688. PubMed ID: 29663885
[TBL] [Abstract][Full Text] [Related]
23. Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.
Kraft JC; Freeling JP; Wang Z; Ho RJ
J Pharm Sci; 2014 Jan; 103(1):29-52. PubMed ID: 24338748
[TBL] [Abstract][Full Text] [Related]
24. Engineering liposomal nanoparticles for targeted gene therapy.
Zylberberg C; Gaskill K; Pasley S; Matosevic S
Gene Ther; 2017 Aug; 24(8):441-452. PubMed ID: 28504657
[TBL] [Abstract][Full Text] [Related]
25. From conventional to stealth liposomes: a new Frontier in cancer chemotherapy.
Cattel L; Ceruti M; Dosio F
J Chemother; 2004 Nov; 16 Suppl 4():94-7. PubMed ID: 15688621
[TBL] [Abstract][Full Text] [Related]
26. Development of a novel liposomal nanoparticle formulation of cisplatin to breast cancer therapy.
Ghafari M; Haghiralsadat F; Khanamani Falahati-Pour S; Zavar Reza J
J Cell Biochem; 2020 Jul; 121(7):3584-3592. PubMed ID: 31907989
[TBL] [Abstract][Full Text] [Related]
27. Liposomal Nanostructures for Drug Delivery in Gastrointestinal Cancers.
Das M; Huang L
J Pharmacol Exp Ther; 2019 Sep; 370(3):647-656. PubMed ID: 30541917
[TBL] [Abstract][Full Text] [Related]
28. Development of Liposomal Formulation for Delivering Anticancer Drug to Breast Cancer Stem-Cell-Like Cells and its Pharmacokinetics in an Animal Model.
Ahmad A; Mondal SK; Mukhopadhyay D; Banerjee R; Alkharfy KM
Mol Pharm; 2016 Mar; 13(3):1081-8. PubMed ID: 26832839
[TBL] [Abstract][Full Text] [Related]
29. Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment.
Juan A; Cimas FJ; Bravo I; Pandiella A; Ocaña A; Alonso-Moreno C
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825618
[TBL] [Abstract][Full Text] [Related]
30. GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancers.
Xu WW; Liu DY; Cao YC; Wang XY
Int J Nanomedicine; 2017; 12():6461-6470. PubMed ID: 28919747
[TBL] [Abstract][Full Text] [Related]
31. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y
Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779
[TBL] [Abstract][Full Text] [Related]
32. Development of a Liposomal Formulation of Acetyltanshinone IIA for Breast Cancer Therapy.
Wang Q; Luo M; Wei N; Chang A; Luo KQ
Mol Pharm; 2019 Sep; 16(9):3873-3886. PubMed ID: 31389706
[TBL] [Abstract][Full Text] [Related]
33. Application of nanoparticles in drug delivery for the treatment of osteosarcoma: focussing on the liposomes.
Liang W; Dong Y; Shao R; Zhang S; Wu X; Huang X; Sun B; Zeng B; Zhao J
J Drug Target; 2022 Jun; 30(5):463-475. PubMed ID: 34962448
[TBL] [Abstract][Full Text] [Related]
34. Nanomedicine for Treatment of Lung Cancer.
Hussain S
Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
[TBL] [Abstract][Full Text] [Related]
35. Cetuximab-Coated Thermo-Sensitive Liposomes Loaded with Magnetic Nanoparticles and Doxorubicin for Targeted EGFR-Expressing Breast Cancer Combined Therapy.
Dorjsuren B; Chaurasiya B; Ye Z; Liu Y; Li W; Wang C; Shi D; Evans CE; Webster TJ; Shen Y
Int J Nanomedicine; 2020; 15():8201-8215. PubMed ID: 33122906
[TBL] [Abstract][Full Text] [Related]
36. Tumor targeting using liposomal antineoplastic drugs.
Huwyler J; Drewe J; Krähenbuhl S
Int J Nanomedicine; 2008; 3(1):21-9. PubMed ID: 18488413
[TBL] [Abstract][Full Text] [Related]
37. Targeted Delivery of Doxorubicin Liposomes for Her-2+ Breast Cancer Treatment.
Chowdhury N; Chaudhry S; Hall N; Olverson G; Zhang QJ; Mandal T; Dash S; Kundu A
AAPS PharmSciTech; 2020 Jul; 21(6):202. PubMed ID: 32696338
[TBL] [Abstract][Full Text] [Related]
38. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
39. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
40. Nanoparticles containing insoluble drug for cancer therapy.
Guo S; Huang L
Biotechnol Adv; 2014; 32(4):778-88. PubMed ID: 24113214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
